Swiss Re, CH0126881561

Swiss Re with a clear analyst consensus, shares anchored in the SMI

Published on 06/24/2026 at 08:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Swiss Re attracts a broadly positive analyst stance on SIX Swiss Exchange, with most houses rating the reinsurer as a Buy while monitoring capital returns and catastrophe exposure.

Swiss Re, CH0126881561, Illustration mit AI erstellt.
Swiss Re, CH0126881561, Illustration mit AI erstellt.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-24, 08:46.

Swiss Re (CH0126881561) stands out on SIX Swiss Exchange in Zurich with a broadly positive analyst stance on the reinsurer's shares. Current consensus data show a clear tilt towards Buy recommendations and expectations of robust capital returns, as compiled by MarketScreener.

What the analyst votes show

Analyst surveys for Swiss Re cluster around a predominately positive view, with a majority of research houses rating the shares Buy or Outperform and a smaller group staying Neutral, according to aggregated data on MarketScreener. MarketScreener consensus overview The consensus 12-month price target sits above the current share price in Swiss francs, indicating room for upside in the average analyst model.

Large international banks such as UBS and JPMorgan regularly update their views on Swiss Re and focus on solvency, dividend capacity and the quality of underwriting earnings across property-catastrophe and life reinsurance lines. UBS research portal The reinsurer's role as one of the heavyweights in the Swiss Market Index (SMI) supports steady coverage intensity from European and US research desks.

How Swiss Re sits in the peer group

In the European insurance space, Swiss Re is typically benchmarked against Munich Re and Hannover Re, as well as primary insurer Zurich Insurance, when analysts compare valuation multiples and capital strength. Reuters company overview on Swiss Re Price-to-book and dividend yield often form the core metrics in these comparison tables.

While Munich Re and Hannover Re lean heavily on reinsurance, Zurich Insurance combines primary insurance with some reinsurance exposure, giving analysts a broader cross-check for sector trends in pricing cycles, natural catastrophe losses and regulatory capital demands under frameworks such as Solvency II in Europe and the Swiss Solvency Test.

Go deeper

All news and analysis on the Swiss Re shares

Further background, ad-hoc releases and historical price data on Swiss Re are bundled in the dedicated topic section and on the company's investor relations pages.

How Swiss Re earns its money

Swiss Re generates most of its income by assuming insurance risks from primary insurers and large corporations in exchange for reinsurance premiums, providing capacity for natural catastrophe, property and casualty, and life and health risks. Swiss Re financial information The group complements underwriting income with investment returns on its global fixed income and equity portfolio.

Where the Swiss Re shares trade today

The Swiss Re shares (CH0126881561) trade on SIX Swiss Exchange in Zurich, with the latest price quoted in Swiss francs on the Swiss blue-chip segment alongside their inclusion in the Swiss Market Index.

Key data on the Swiss Re shares

  • Company: Swiss Re AG
  • ISIN: CH0126881561
  • WKN: A1H81M
  • Ticker: SREN
  • Trading venue: SIX Swiss Exchange
  • Price (as of 2026-06-24, 08:30): 109.00 CHF
  • Market cap: 31.0 billion CHF (as of 2026-06-24)
  • Sector / industry: Financials / Reinsurance
  • Index membership: Swiss Market Index (SMI)
  • Next earnings date: 2026-08-08

More on the Swiss Re shares in social media

This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial guidance. Readers should conduct their own research and, where appropriate, consult a qualified financial adviser before making investment decisions.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CH0126881561 | SWISS RE | boerse | 69616353 | bgmi